Share Vaccine and Infectious Disease Division
VIDD researchers receive $14.5M NIH grant for STI research
July 23, 2014 in VIDD News
CDC recommends daily pill for those at high risk for HIV
May 16, 2014 in VIDD News
VIDD Member Peter Gilbert receives ASA award
VIDD Member Dr. Peter Gilbert was selected as a Fellow of the American Statistical Association for his tremendous contribution to the field of biostatistics.
April 23, 2014 in VIDD News
Glenda Gray appointed new president of South African Medical Research Council
HIV expert Dr. Glenda Gray, VIDD member and co-principal investigator of the HIV Vaccine Trials Network (HVTN), has been named president of the South African Medical Research Council, the premier medical research organization and funder of medical research in South Africa.
March 24, 2014 in VIDD News
VIDD Welcomes Curt Malloy, new Division Administrator
VIDD would like to announce that Curt Malloy, JD, MPH will become the new VIDD Administrator effective February 17, 2014.
March 6, 2014 in VIDD News
VIDD Thanks Leslie Sandberg, outgiong Division Administrator
After nearly two years of dedicated service, Leslie Sandberg will, effective February 7th, be leaving VIDD to assume the Division Administrator role for the Center’s Clinical Research Division (CRD).
Feb. 6, 2014 in VIDD News
HIV Vaccine Trials Network among five nationwide selected to receive seven-year award
The HIV Vaccine Trials Network, part of the Vaccine and Infectious Disease Division, is among five clinical trial networks across the United States that will receive substantial federal funding to continue their work in the fight against HIV/AIDS.
Jan. 15, 2014 in VIDD News
South Africa Mourns Nelson Mandela's Death
Today the flags in South Africa fly at half-mast as we mourn the passing of the father of our nation. Nelson Mandela passed away last night at the age of 95, one of the icons of modern history, our own South African who became the face of freedom, not only for us, but for all the oppressed, the eternal symbol of freedom.
Dec. 6, 2013 in VIDD News
Fighting HIV on its Own Turf
Three years ago, VIDD scientists decided their best shot at developing an effective HIV vaccine was to try and beat the virus on its own turf, by launching clinical trials in a country that had lost an entire generation to AIDS: South Africa.
Oct. 21, 2013 in VIDD News
Genital Herpes-Suppressing Immune Cells Identified
Scientists at the Hutchinson Center Vaccine and Infectious Disease Division and University of Washington have identified a class of immune cells that reside long-term in the genital skin and mucosa and are believed to be responsible for suppressing recurring outbreaks of genital herpes.
May 8, 2013 in VIDD News
South African HVTN Researcher Receives Highest Civilian Award
HVTN investigator Dr. Glenda Gray, one of the world’s foremost authorities on the HIV epidemic in sub-Saharan Africa, is honored by South African President Jacob Zuma for her substantial achievements in designing, implementing and overseeing HIV vaccine trials, as well as ensuring those in most need of prevention and treatment measures benefit from advances made by the HIV/AIDS biomedical community.
May 8, 2013 in VIDD News
VIDD's Joshua Hill Wins Publication Prize
The Vaccine and Infectious Disease Division's Dr. Joshua Hill is the recipient of the Biology of Blood and Marrow Transplantation's 2012 George Santos Award for best clinical science article by a new investigator.
Feb. 19, 2013 in VIDD News
VIDD Plays Integral Role in Recent HIV Vaccine Breakthroughs
In 2009, the results of an HIV vaccine clinical trial sponsored by the Thai Ministry of Health and U.S. Military HIV Research Program galvanized the worldwide HIV vaccine community.
Oct. 22, 2012 in VIDD News
HPTN 052: Science Breakthrough of the Year, 2011
Every year, Science announces the Breakthrough of the Year, an honor bestowed to research that impacts a wide array of scientists and has far-reaching and profound implications.
Jan. 9, 2012 in VIDD News
The Hutchinson Center's world-renowned scientists are discovering new ways to detect, prevent and treat cancer, HIV/AIDS and many other diseases.
The Hutchinson Center's world-renowned researchers work together to pursue lifesaving therapies that will help eliminate cancer and related diseases.
The Hutchinson Center's clinical research breakthroughs are delivered to patients through our treatment arm, the Seattle Cancer Care Alliance. This collaboration combines the strengths of the Hutchinson Center, UW Medicine and Seattle Children's.
You can help eliminate cancer and related diseases by attending Hutchinson Center events and participating in our other fundraising and community efforts.
The Hutchinson Center's pioneering researchers push the boundaries of science to find new ways to prevent, detect and treat cancer and related diseases.
Private support is critical to fund new research ideas and innovations, accelerating our ability to make lifesaving discoveries.